ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
Dow Jones
39.872,99
0,17%
Euro vs US Dollar
1,08582
-0,02%
Bitcoin
70.119,42
-1,86%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Sanara MedTech Inc (SMTI)

  7. Sanara MedTech Inc (SMTI) News

SMTI

Sanara MedTech (SMTI)

Sanara MedTech Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SMTI
DatumZeitQuelleÜberschriftSymbolFirma
21/05/202422h39Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SMTISanara MedTech Inc
15/05/202422h39Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SMTISanara MedTech Inc
13/05/202422h09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SMTISanara MedTech Inc
13/05/202415h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMTISanara MedTech Inc
13/05/202415h15GlobeNewswire Inc.Sanara MedTech Inc. Announces First Quarter 2024 ResultsNASDAQ:SMTISanara MedTech Inc
29/04/202415h15GlobeNewswire Inc.Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call DatesNASDAQ:SMTISanara MedTech Inc
18/04/202415h15GlobeNewswire Inc.Sanara MedTech Inc. Announces $55 Million Debt FacilityNASDAQ:SMTISanara MedTech Inc
05/04/202415h00GlobeNewswire Inc.Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy OfficerNASDAQ:SMTISanara MedTech Inc
25/03/202421h05GlobeNewswire Inc.Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 ResultsNASDAQ:SMTISanara MedTech Inc
13/03/202414h15GlobeNewswire Inc.Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call DatesNASDAQ:SMTISanara MedTech Inc
11/03/202421h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SMTISanara MedTech Inc
11/03/202421h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SMTISanara MedTech Inc
06/03/202400h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SMTISanara MedTech Inc
06/03/202400h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SMTISanara MedTech Inc
22/02/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMTISanara MedTech Inc
22/02/202415h15GlobeNewswire Inc.Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023NASDAQ:SMTISanara MedTech Inc
06/02/202400h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SMTISanara MedTech Inc
06/02/202400h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SMTISanara MedTech Inc
03/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SMTISanara MedTech Inc
03/01/202415h15GlobeNewswire Inc.Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen PeptidesNASDAQ:SMTISanara MedTech Inc
30/11/202315h15GlobeNewswire Inc.Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound HealingNASDAQ:SMTISanara MedTech Inc
13/11/202322h42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMTISanara MedTech Inc
13/11/202322h05GlobeNewswire Inc.Sanara MedTech Inc. Announces Third Quarter 2023 ResultsNASDAQ:SMTISanara MedTech Inc
13/11/202322h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SMTISanara MedTech Inc
30/10/202314h15GlobeNewswire Inc.Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call DatesNASDAQ:SMTISanara MedTech Inc
10/10/202315h15GlobeNewswire Inc.Sanara MedTech Announces First Sale of ALLOCYTE® Plus Advanced Viable Bone Matrix and Provides Other Product UpdatesNASDAQ:SMTISanara MedTech Inc
22/09/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SMTISanara MedTech Inc
19/09/202314h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMTISanara MedTech Inc
12/09/202315h15GlobeNewswire Inc.Sanara MedTech to Participate in Two Upcoming ConferencesNASDAQ:SMTISanara MedTech Inc
16/08/202312h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SMTISanara MedTech Inc
 Showing the most relevant articles for your search:NASDAQ:SMTI

Kürzlich von Ihnen besucht

NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
NYSE
KO
Coca Cola
USOTC
ADDYY
Adidas (QX)
AMEX
XLE
Energy Select Sector SPDR
NYSE
JPM
JP Morgan Chase
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
FX
EURGBP
Euro vs Sterling
TG
DBK
Deutsche Bank
CCOM
US100
US Tech 100
TG
ALV
Allianz
DBI
MDAX
MDAX
DBI
SDXP
SDAX
TG
DTE
Deutsche Telekom
DBI
TDXP
Tec DAX
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten